Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Alberts

Showing results (171-180 of 184) with videos related to

Pageof 19
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|February 14, 2018
Pharmacological TLR4 Antagonism Using Topical Resatorvid Blocks Solar UV-Induced Skin Tumorigenesis in SKH-1 MiceKaren Blohm-Mangone, Nichole B Burkett, Shekha Tahsin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2009
Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer IntergroupMichael A Bookman, Mark F Brady, William P McGuire, et al.
Gynecologic Oncology|January 6, 2023
Lifestyle intervention in ovarian cancer enhanced survival (LIVES) study (NRG/GOG0225): Recruitment, retention and baseline characteristics of a randomized trial of diet and physical activity in ovarian cancer survivorsCynthia A Thomson, Tracy E Crane, Austin Miller, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 24, 2016
Inhibition of Akt Enhances the Chemopreventive Effects of Topical Rapamycin in Mouse SkinSally E Dickinson, Jaroslav Janda, Jane Criswell, et al.
Gynecologic Oncology|November 5, 2019
GOG 244 - The LymphEdema and Gynecologic cancer (LEG) study: The association between the gynecologic cancer lymphedema questionnaire (GCLQ) and lymphedema of the lower extremity (LLE)Jeanne Carter, Helen Q Huang, Jane Armer, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 8, 2011
Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917James R Marshall, Catherine M Tangen, Wael A Sakr, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 28, 2010
A phase 2a study of topical perillyl alcohol cream for chemoprevention of skin cancerSteven P Stratton, David S Alberts, Janine G Einspahr, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 13, 2012
Design and baseline characteristics of participants in a phase III randomized trial of celecoxib and selenium for colorectal adenoma preventionPatricia Thompson, Denise J Roe, Liane Fales, et al.
Journal of the National Cancer Institute|August 18, 2016
Celecoxib for the Prevention of Colorectal Adenomas: Results of a Suspended Randomized Controlled TrialPatricia A Thompson, Erin L Ashbeck, Denise J Roe, et al.
Journal of the National Cancer Institute|August 18, 2016
Selenium Supplementation for Prevention of Colorectal Adenomas and Risk of Associated Type 2 DiabetesPatricia A Thompson, Erin L Ashbeck, Denise J Roe, et al.
Pageof 19

Showing results (171-180 of 184) with videos related to

Sort By:
Pageof 19
Cancer Prevention Research (Philadelphia, Pa.)|February 14, 2018
Pharmacological TLR4 Antagonism Using Topical Resatorvid Blocks Solar UV-Induced Skin Tumorigenesis in SKH-1 MiceKaren Blohm-Mangone, Nichole B Burkett, Shekha Tahsin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2009
Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer IntergroupMichael A Bookman, Mark F Brady, William P McGuire, et al.
Gynecologic Oncology|January 6, 2023
Lifestyle intervention in ovarian cancer enhanced survival (LIVES) study (NRG/GOG0225): Recruitment, retention and baseline characteristics of a randomized trial of diet and physical activity in ovarian cancer survivorsCynthia A Thomson, Tracy E Crane, Austin Miller, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 24, 2016
Inhibition of Akt Enhances the Chemopreventive Effects of Topical Rapamycin in Mouse SkinSally E Dickinson, Jaroslav Janda, Jane Criswell, et al.
Gynecologic Oncology|November 5, 2019
GOG 244 - The LymphEdema and Gynecologic cancer (LEG) study: The association between the gynecologic cancer lymphedema questionnaire (GCLQ) and lymphedema of the lower extremity (LLE)Jeanne Carter, Helen Q Huang, Jane Armer, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 8, 2011
Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917James R Marshall, Catherine M Tangen, Wael A Sakr, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 28, 2010
A phase 2a study of topical perillyl alcohol cream for chemoprevention of skin cancerSteven P Stratton, David S Alberts, Janine G Einspahr, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 13, 2012
Design and baseline characteristics of participants in a phase III randomized trial of celecoxib and selenium for colorectal adenoma preventionPatricia Thompson, Denise J Roe, Liane Fales, et al.
Journal of the National Cancer Institute|August 18, 2016
Celecoxib for the Prevention of Colorectal Adenomas: Results of a Suspended Randomized Controlled TrialPatricia A Thompson, Erin L Ashbeck, Denise J Roe, et al.
Journal of the National Cancer Institute|August 18, 2016
Selenium Supplementation for Prevention of Colorectal Adenomas and Risk of Associated Type 2 DiabetesPatricia A Thompson, Erin L Ashbeck, Denise J Roe, et al.
Pageof 19